1Ferlay J,Shin HR,Bray F. Estimates of worldwide burden ofcancer in 2008:GLOBOCAN 2008[J].International Journal of Cancer,2010,(12):2893-2917.
2Antman K,Ayash L,Elias A. A phase II study of high-dosecyclophosphamide,thiotepa,and carboplatin with autologousmarrow support in women with measurable advanced breastcancer responding to standard-dose therapy[J].Journal of Clinical Oncology,1992,(01):102-110.
3Antman KH. New developments in clinical oncology:The interdependenceof bench and bedside[J].Cancer Research,1991,(Suppl 18):5060s-5064s.
4Henderson IC,Berry DA,Demetri GD. Improved outcomes fromadding sequential paclitaxel but not from escalating doxorubicindose in an adjuvant chemotherapy regimen for patients with nodepositiveprimary breast cancer[J].Journal of Clinical Oncology,2003,(06):976-983.
6Berry DA,Ueno NT. High-dose chemotherapy with autologousstem-cell support as adjuvant therapy in breast cancer:overviewof 15 randomized trials[J].Journal of Clinical Oncology,2011,(24):3214-3223.
7Stadtmauer EA,O'Neill A,Goldstein LJ. Conventional-dosechemotherapy compared with highdose chemotherapy (HDC) plusautologous stem-cell transplantation (SCT) for metastatic breastcancer:5-year update of the ‘Philadelphia Trial' (PBT-1)[J].Proceedings of the American Society of Clinical Oncology,2002.abstr169.
8Berry DA,Ueno NT. High-dose chemotherapy with autologoushematopoietic stem-cell transplantation in metastatic breast cancer:overview of six randomized trials[J].Journal of Clinical Oncology,2011,(24):3224-3231.
5Jemal A,Siegel R,Ward E,et al.Cancer statistics[J].CA Cancer J Clin,2008,58(2):71-96.
6Brinton LA,Sherman ME,Carreon JD,et al.Recent trends in breast cancer among younger women in the United States[J].J Natl Cancer Inst,2008,100(22):1643-1648.
7Korea Central Cancer Registry,Ministry of Health and Welfare,Republic of Korea 2002 Annual Report of the Korea Central Cancer Registry Seoul,Korea[R].Korea Central Cancer Registry,2003:4-5.
8Han W,Kim SW,Park IA,et al.Young age:an independent risk factor for disease-free survival in women with operable breast cancer[J].BMC Cancer,2004,4(82):2360-2368.
9Kim JK,Kwak BS,Lee JS,et al.Do very young Korean breast cancer patients have worse outcomes?[J].Ann Surg Oncol,2007,14(12):3385-3391.
10Albain KS,Allred DC,Clark GM.Breast cancer outcome and predictors of outcome:are there age differentials?[J].J Natl Cancer Inst Monogr,1994(16):35-42.
